Comprehensive Metabolic Panel (CMP) Testing Market (Test Type: Glucose, Calcium, Electrolytes, Kidney Function tests, Liver Function Tests, and Others; Disease Indication: Kidney Diseases, Liver Diseases, Diabetes, and Others) - Global Industry Analysis,

Comprehensive Metabolic Panel (CMP) Testing Market (Test Type: Glucose, Calcium, Electrolytes, Kidney Function tests, Liver Function Tests, and Others; Disease Indication: Kidney Diseases, Liver Diseases, Diabetes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Comprehensive Metabolic Panel (CMP) Testing Market – Scope of Report

TMR’s report on the global comprehensive metabolic panel (CMP) testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global comprehensive metabolic panel (CMP) testing market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global comprehensive metabolic panel (CMP) testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the comprehensive metabolic panel (CMP) testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global comprehensive metabolic panel (CMP) testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global comprehensive metabolic panel (CMP) testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global comprehensive metabolic panel (CMP) testing market.

The report delves into the competitive landscape of the global comprehensive metabolic panel (CMP) testing market. Key players operating in the global comprehensive metabolic panel (CMP) testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global comprehensive metabolic panel (CMP) testing market profiled in this report.

Key Questions Answered in Global comprehensive metabolic panel (CMP) testing Market Report
  • What is the sales/revenue generated by comprehensive metabolic panel (CMP) testing across all regions during the forecast period?
  • What are the opportunities in the global comprehensive metabolic panel (CMP) testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Comprehensive Metabolic Panel (CMP) Testing Market – Research Objectives and Research Approach

The comprehensive report on the global comprehensive metabolic panel (CMP) testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global comprehensive metabolic panel (CMP) testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global comprehensive metabolic panel (CMP) testing market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Comprehensive Metabolic Panel (CMP) Testing Market
4. Market Overview
  4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product /Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Test Type
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Test Type, 2020-2034
6.3.1. Glucose
6.3.2. Calcium
6.3.3. Electrolytes
6.3.4. Kidney Function Tests
6.3.5. Liver Function Tests
6.3.6. Others (Protein, etc.)
  6.4. Market Attractiveness Analysis, by Test Type
7. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Disease Indication
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Disease Indication, 2020-2034
7.3.1. Kidney Diseases
7.3.2. Liver Diseases
7.3.3. Diabetes
7.3.4. Others (Hypertension, etc.)
  7.4. Market Attractiveness Analysis, by Disease Indication
8. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by End-user
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Clinics
8.3.2. Diagnostic Laboratories
8.3.3. Others (Research Institutes, etc.)
  8.4. Market Attractiveness Analysis, by End-user
9. Global Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast, by Region
  9.1. Key Findings
  9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
  9.3. Market Attractiveness Analysis, by Region
10. North America Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
  10.1. Introduction
  10.2. Key Findings
  10.3. Market Value Forecast, by Test Type, 2020-2034
10.3.1. Glucose
10.3.2. Calcium
10.3.3. Electrolytes
10.3.4. Kidney Function Tests
10.3.5. Liver Function Tests
10.3.6. Others (Protein, etc.)
  10.4. Market Value Forecast, by Disease Indication, 2020-2034
10.4.1. Kidney Diseases
10.4.2. Liver Diseases
10.4.3. Diabetes
10.4.4. Others (Hypertension, etc.)
  10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Clinics
10.5.2. Diagnostic Laboratories
10.5.3. Others (Research Institutes, etc.)
  10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
  10.7. Market Attractiveness Analysis
10.7.1. By Test Type
10.7.2. By Disease Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
  11.1. Introduction
  11.2. Key Findings
  11.3. Market Value Forecast, by Test Type, 2020-2034
11.3.1. Glucose
11.3.2. Calcium
11.3.3. Electrolytes
11.3.4. Kidney Function Tests
11.3.5. Liver Function Tests
11.3.6. Others (Protein, etc.)
  11.4. Market Value Forecast, by Disease Indication, 2020-2034
11.4.1. Kidney Diseases
11.4.2. Liver Diseases
11.4.3. Diabetes
11.4.4. Others (Hypertension, etc.)
  11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Clinics
11.5.2. Diagnostic Laboratories
11.5.3. Others (Research Institutes, etc.)
  11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
  11.7. Market Attractiveness Analysis
11.7.1. By Test Type
11.7.2. By Disease Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
  12.1. Introduction
  12.2. Key Findings
  12.3. Market Value Forecast, by Test Type, 2020-2034
12.3.1. Glucose
12.3.2. Calcium
12.3.3. Electrolytes
12.3.4. Kidney Function Tests
12.3.5. Liver Function Tests
12.3.6. Others (Protein, etc.)
  12.4. Market Value Forecast, by Disease Indication, 2020-2034
12.4.1. Kidney Diseases
12.4.2. Liver Diseases
12.4.3. Diabetes
12.4.4. Others (Hypertension, etc.)
  12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Clinics
12.5.2. Diagnostic Laboratories
12.5.3. Others (Research Institutes, etc.)
  12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
  12.7. Market Attractiveness Analysis
12.7.1. By Test Type
12.7.2. By Disease Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
  13.1. Introduction
  13.2. Key Findings
  13.3. Market Value Forecast, by Test Type, 2020-2034
13.3.1. Glucose
13.3.2. Calcium
13.3.3. Electrolytes
13.3.4. Kidney Function Tests
13.3.5. Liver Function Tests
13.3.6. Others (Protein, etc.)
  13.4. Market Value Forecast, by Disease Indication, 2020-2034
13.4.1. Kidney Diseases
13.4.2. Liver Diseases
13.4.3. Diabetes
13.4.4. Others (Hypertension, etc.)
  13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Clinics
13.5.2. Diagnostic Laboratories
13.5.3. Others (Research Institutes, etc.)
  13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
  13.7. Market Attractiveness Analysis
13.7.1. By Test Type
13.7.2. By Disease Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Analysis and Forecast
  14.1. Introduction
  14.2. Key Findings
  14.3. Market Value Forecast, by Test Type, 2020-2034
14.3.1. Glucose
14.3.2. Calcium
14.3.3. Electrolytes
14.3.4. Kidney Function Tests
14.3.5. Liver Function Tests
14.3.6. Others (Protein, etc.)
  14.4. Market Value Forecast, by Disease Indication, 2020-2034
14.4.1. Kidney Diseases
14.4.2. Liver Diseases
14.4.3. Diabetes
14.4.4. Others (Hypertension, etc.)
  14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Clinics
14.5.2. Diagnostic Laboratories
14.5.3. Others (Research Institutes, etc.)
  14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
  14.7. Market Attractiveness Analysis
14.7.1. By Test Type
14.7.2. By Disease Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  15.2. Market Share Analysis, by Company (2023)
  15.3. Company Profiles
15.3.1. Roche Diagnostics
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Scion Lab Services, LLC
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Baptist Health
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Walk-in Lab, LLC
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Testing.com
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. My Care Labs
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. ARUP Laboratories
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Blueprint Genetics Oy
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Applied InGENuity Diagnostics
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Quest Diagnostics
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings